Vai al contenuto

Interazioni tra farmaci

Aprepitant + Cobimetinib

Gravità: Maggiore

Aprepitant and Cobimetinib: major interaction.

Ultimo aggiornamento

Per operatori sanitari — solo a scopo di riferimento. Questa pagina è una sintesi breve, non è un parere medico e non sostituisce il RCP ufficiale né il giudizio clinico. Verificare sempre prima di prescrivere o dispensare.

Il contenuto clinico di questa pagina è disponibile solo in inglese.

Sintesi

Aprepitant is a moderate CYP3A4 inhibitor and can raise cobimetinib concentrations. This increases the risk of cobimetinib toxicity such as rash, diarrhea, hemorrhage, liver injury and retinopathy.

Cosa significa questa interazione in parole semplici

Aprepitant and Cobimetinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Aprepitant belongs to Gastrointestinal Tract; Cobimetinib belongs to Oncology.

Livello di evidenza: Moderate

Perché avviene

Aprepitant inhibits CYP3A4, reducing the metabolism of cobimetinib, a CYP3A substrate.

Cosa fare

Avoid the combination and use an alternative antiemetic. If short-term use is unavoidable, reduce cobimetinib to 20 mg daily as labeled and monitor closely for toxicity.

Cosa chiedere al farmacista

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Per gli utenti Pro+

Sblocca la pagina completa

Crei un account e avvii una prova di Pro+ per sbloccare le indicazioni complete sulla gestione di Aprepitant e Cobimetinib, le note aggiuntive, il dettaglio delle evidenze e il controllo delle interazioni per un'intera prescrizione.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Provi Pro+ gratis per 14 giorni sul web. Nessuna carta.

Domande frequenti

Can I take Aprepitant with Cobimetinib?

MediHelp rates the interaction as major. Aprepitant and Cobimetinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Aprepitant is a moderate CYP3A4 inhibitor and can raise cobimetinib concentrations. This increases the risk of cobimetinib toxicity such as rash, diarrhea, hemorrhage, liver injury and retinopathy.

How serious is the interaction between Aprepitant and Cobimetinib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination and use an alternative antiemetic. If short-term use is unavoidable, reduce cobimetinib to 20 mg daily as labeled and monitor closely for toxicity.

What other medicines interact with Aprepitant?

MediHelp also lists interactions of Aprepitant with, for example, Lomitapide, Pimozide, Avapritinib. The full list is on the Aprepitant page.

Monografie complete, posologie e verifica delle interazioni nell'app MediHelp

Apra il riferimento completo, verifichi le interazioni tra più farmaci e usi gli strumenti di posologia nell'app MediHelp.

Sfoglia dalla A alla Z · Interazioni tra farmaci

Scarica l'app Accedi